LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Luan, Xiaoyang"
  2. AU="Goberdhan, Sankalp"
  3. AU="Krammer, Sandy"
  4. AU="Whitehorne-Smith, Patrice"
  5. AU="Witek, M." AU="Witek, M."
  6. AU="Steiner, Luzius A"
  7. AU=Williams Kirryn
  8. AU="Rossi, Simone"
  9. AU="Bryan, Nathan S."
  10. AU="Sodhi, Sohail"
  11. AU="Sotiropoulos, Thodoris"
  12. AU="Osborne, Cameron"
  13. AU="Seira, Jordan"
  14. AU="Komiya, Ryota"
  15. AU="Yeonsoo Joe"
  16. AU="Christina Drake"
  17. AU="Rosenbloom, E Scott"
  18. AU="Clémentine Schilte"
  19. AU="Montanari, Andrea"
  20. AU="Salehi Karizmeh, Mojtaba"
  21. AU="Svanberg Frisinger, Frida"
  22. AU="Iyappan, Petchi"
  23. AU="Naomi Nakagata"
  24. AU="Marianne A. van der Sande"
  25. AU="Reno, Chiara"

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: N-Acetylglucosamine mitigates lung injury and pulmonary fibrosis induced by bleomycin.

Li, Jinyu / Xu, Xiaohui / Liu, Jiane / Chen, Yunqing / Jin, Shengxi / Zhang, Guangmin / Yin, Shulan / Wang, Jingqi / Tian, Kangqi / Luan, Xiaoyang / Tan, Xiaohua / Zhao, Xiangzhong / Zhang, Na / Wang, Zheng

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

2023  Band 166, Seite(n) 115069

Abstract: Lung injury and pulmonary fibrosis contribute to morbidity and mortality, and, in particular, are characterized as leading cause on confirmed COVID-19 death. To date, efficient therapeutic approach for such lung diseases is lacking. N-Acetylglucosamine ( ... ...

Abstract Lung injury and pulmonary fibrosis contribute to morbidity and mortality, and, in particular, are characterized as leading cause on confirmed COVID-19 death. To date, efficient therapeutic approach for such lung diseases is lacking. N-Acetylglucosamine (NAG), an acetylated derivative of glucosamine, has been proposed as a potential protector of lung function in several types of lung diseases. The mechanism by which NAG protects against lung injury, however, remains unclear. Here, we show that NAG treatment improves pulmonary function in bleomycin (BLM)-induced lung injury model measured by flexiVent system. At early phase of lung injury, NAG treatment results in silenced immune response by targeting ARG1
Mesh-Begriff(e) Humans ; Pulmonary Fibrosis/chemically induced ; Pulmonary Fibrosis/drug therapy ; Pulmonary Fibrosis/prevention & control ; Lung Injury/chemically induced ; Lung Injury/drug therapy ; Acetylglucosamine ; Bleomycin/toxicity ; COVID-19
Chemische Substanzen Acetylglucosamine (V956696549) ; Bleomycin (11056-06-7)
Sprache Englisch
Erscheinungsdatum 2023-08-24
Erscheinungsland France
Dokumenttyp Journal Article
ZDB-ID 392415-4
ISSN 1950-6007 ; 0753-3322 ; 0300-0893
ISSN (online) 1950-6007
ISSN 0753-3322 ; 0300-0893
DOI 10.1016/j.biopha.2023.115069
Signatur
Ud II Zs.198: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang